Surprising leads for a cholera toxin receptor-binding antagonist: crystallographic studies of CTB mutants.
Merritt, E.A., Sarfaty, S., Chang, T.T., Palmer, L.M., Jobling, M.G., Holmes, R.K., Hol, W.G.(1995) Structure 3: 561-570
- PubMed: 8590017 
- DOI: 10.1016/s0969-2126(01)00190-3
- Primary Citation of Related Structures:  
1CHP, 1CHQ - PubMed Abstract: 
Because agents which inhibit the receptor binding of cholera toxin constitute possible lead compounds for the structure-based design of anti-cholera drugs, detailed investigation of the toxin's receptor-binding site is of key importance. The substitution Gly-->Asp at residue 33 of the cholera toxin B subunit (CTB) has been reported to abolish receptor-binding ability ...